Inflation has returned with force in 2026. The April Consumer Price Index came in at 3.8% year-over-year — the hottest reading since May 2023 — followed a day later by an even bigger surprise: the Producer Price Index surged 6.0% year-over-year, the largest wholesale inflation print since December 2022. The 30-year Treasury yield has eclipsed 5%, and the 10-year sits near 4.49%.
For ETF investors, the message is clear: inflation protection is no longer optional. Here are the funds best positioned to help.
TIPS ETFs: Direct Inflation Linkage
Treasury Inflation-Protected Securities remain the most straightforward inflation hedge available in ETF form. TIPS principal adjusts upward with CPI, meaning investors earn a real return above whatever inflation turns out to be.
The iShares TIPS Bond ETF (TIP) is the category leader with roughly $15 billion in assets and deep liquidity. It holds the full maturity spectrum of TIPS, giving broad exposure to inflation-linked Treasuries. The fund charges 0.18% annually.
For investors who want inflation protection without taking on significant duration risk — a real concern with the 30-year yield past 5% — the iShares 0-5 Year TIPS Bond ETF (STIP) concentrates on the short end of the TIPS curve. It carries meaningfully less interest-rate sensitivity than TIP while still capturing CPI adjustments. The Vanguard Short-Term Inflation-Protected Securities ETF (VTIP) offers a similar short-duration TIPS approach at just 0.03% — one of the cheapest inflation-protection ETFs available.
The Schwab U.S. TIPS ETF (SCHP) rounds out the core TIPS lineup at 0.03%, making it the lowest-cost option for investors who want full-curve TIPS exposure. SCHP returned roughly 1.5% through April 2026, modest but positive in a tough bond environment.
Commodity ETFs: The Tangible Inflation Hedge
Commodities have historically been among the strongest inflation hedges because they are inflation — rising commodity prices flow directly into CPI and PPI readings. In 2026, this relationship has played out dramatically.
The Invesco Optimum Yield Diversified Commodity Strategy ETF (PDBC) is up roughly 30% year-to-date, powered by surging energy prices and broad commodity strength. PDBC holds futures across energy, metals, and agriculture, providing diversified commodity exposure. Critically, it is structured as a 1940 Act open-ended ETF that uses an offshore subsidiary to gain commodity exposure, which means investors receive a standard 1099 form rather than the K-1 tax headache that plagues most commodity funds. Expense ratio: 0.59%.
The Invesco DB Commodity Index Tracking Fund (DBC) tracks a similar basket of more than a dozen commodity futures and has returned roughly 22% over the past 12 months. The key difference: DBC issues K-1 forms, which complicates tax filing for many investors. For taxable accounts, PDBC is generally the cleaner choice.
The iShares S&P GSCI Commodity-Indexed Trust (GSG) tilts more heavily toward energy than its peers, which has been an advantage in 2026 with WTI crude above $101, but it carries higher volatility and also issues K-1 forms.
Energy Equity ETFs: Riding the Oil Boom
Energy equities have been the best-performing corner of the market in 2026, and for good reason. Oil prices remain elevated with WTI above $101 per barrel, the Strait of Hormuz remains disrupted, and Saudi Arabia’s output has dropped to its lowest level since 1990.
The SPDR S&P Oil & Gas Exploration & Production ETF (XOP) is up over 40% year-to-date, making it the standout performer among energy ETFs. XOP equal-weights its holdings across E&P companies, giving more exposure to smaller producers that benefit disproportionately when oil prices are high.
The Energy Select Sector SPDR Fund (XLE) offers a more diversified, cap-weighted approach to energy equities and is up roughly 32% year-to-date. It is heavily weighted toward integrated majors like ExxonMobil and Chevron, which also pay substantial dividends — a dual benefit during inflationary periods.
Ultra-Short Treasuries: The Cash Alternative
While not a traditional inflation hedge, ultra-short Treasury ETFs deserve a place in the inflation conversation because they offer competitive yields with virtually no price risk — a combination that matters when bonds are getting hit from both sides.
The iShares 0-3 Month Treasury Bond ETF (SGOV) has grown to over $85 billion in assets, making it the dominant cash-management ETF. It currently yields roughly 3.9%, and its near-zero duration means it barely flinches when yields move. In an environment where long-duration bond ETFs are getting crushed — TLT has taken significant losses as the 30-year yield crossed 5% — SGOV offers stability while still paying investors to wait.
How to Think About Inflation ETF Positioning
No single ETF solves the inflation problem. The best approach combines multiple tools: TIPS for direct CPI linkage, commodities for tangible asset exposure, energy equities for earnings leverage to higher oil prices, and ultra-short Treasuries for capital preservation.
The key question is duration. In a rising-rate environment driven by persistent inflation, shorter-duration exposures — STIP over TIP, SGOV over AGG — have consistently outperformed. That pattern held through the CPI and PPI double shock this week, and there is little reason to expect it to change until inflation meaningfully decelerates.
For investors who want a single-fund solution, PDBC offers the broadest commodity-based inflation hedge with the cleanest tax structure. For those building a multi-sleeve approach, a combination of VTIP, PDBC, XLE, and SGOV covers the major inflation transmission channels while keeping duration risk manageable.
The one certainty is that after back-to-back inflation surprises, the case for ignoring inflation protection has gotten much harder to make.
This article was generated with the assistance of artificial intelligence and reviewed by ETF.com staff.
Investment Risk Disclosure The information provided on this website is for informational and educational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Nothing on this site should be construed as a recommendation to buy, sell, or hold any security or financial product. General Investment Risks Investing involves risk, including the possible loss of principal. Past performance is not indicative of future results. The value of investments may fluctuate, and investors may receive back less than they originally invested. There is no guarantee that any investment strategy will achieve its objectives. ETF-Specific Risks Exchange-traded funds (ETFs) are subject to risks similar to those of stocks and other equity securities. ETF shares are bought and sold at market price, which may differ from the fund’s net asset value (NAV). Brokerage commissions may apply and will reduce returns. ETFs may be subject to the following additional risks:
Market Risk: The value of an ETF may decline due to broad market fluctuations unrelated to the underlying securities. Liquidity Risk: Some ETFs may have limited trading volume, which could make it difficult to buy or sell shares at a desired price. Tracking Error Risk: An ETF may not perfectly replicate the performance of its benchmark index. Concentration Risk: Sector or thematic ETFs may be concentrated in a particular industry or geography, increasing volatility. Currency Risk: ETFs that invest in international securities may be affected by exchange rate fluctuations. Leverage and Inverse Risk: Leveraged and inverse ETFs are designed for short-term trading and may not be suitable for long-term investors. These products use derivatives and may experience significant losses.
No Warranty While efforts are made to ensure the accuracy of information presented, no warranties are made regarding completeness, accuracy, or timeliness. Information may change without notice. Not a Fiduciary This site does not act as a fiduciary on behalf of any user. Users are encouraged to consult with a registered investment advisor, financial planner, or other qualified professional before making any investment decisions.
